Sonoma Pharmaceuticals (SNOA) Payables (2011 - 2025)

Sonoma Pharmaceuticals' Payables history runs 15 years deep, the most recent figure standing at $2.1 million for Q4 2025.

• In Q4 2025, Payables rose 10.18% year-over-year to $2.1 million; the TTM figure through Dec 2025 stood at $2.1 million (up 10.18% YoY), while the FY2025 annual figure was $2.4 million, up 162.8% from the prior year.
• Payables was $2.1 million for Q4 2025 at Sonoma Pharmaceuticals, up from $1.5 million in the prior quarter.
• In the past five years, Payables ranged from a high of $2.5 million in Q1 2023 to a low of $864000.0 in Q4 2023.
• Historically, Payables has averaged $1.6 million across 5 years, with a median of $1.7 million in 2024.
• The sharpest annual moves came in 2021 and 2025: Payables sank 70.82% in 2021, then jumped 162.8% in 2025.
• A 5-year view of Payables shows it stood at $1.3 million in 2021, then surged by 70.36% to $2.2 million in 2022, then tumbled by 60.75% to $864000.0 in 2023, then jumped by 121.76% to $1.9 million in 2024, then gained by 10.18% to $2.1 million in 2025.
• The last three Payables figures came in at $2.1 million (Q4 2025), $1.5 million (Q3 2025), and $2.0 million (Q2 2025), per Business Quant data.